JPS6221358B2 - - Google Patents
Info
- Publication number
- JPS6221358B2 JPS6221358B2 JP16914080A JP16914080A JPS6221358B2 JP S6221358 B2 JPS6221358 B2 JP S6221358B2 JP 16914080 A JP16914080 A JP 16914080A JP 16914080 A JP16914080 A JP 16914080A JP S6221358 B2 JPS6221358 B2 JP S6221358B2
- Authority
- JP
- Japan
- Prior art keywords
- group
- iodide
- bromide
- chloride
- reaction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- -1 steroid compound Chemical class 0.000 claims description 27
- 125000000217 alkyl group Chemical group 0.000 claims description 9
- 150000003242 quaternary ammonium salts Chemical class 0.000 claims description 8
- 150000001875 compounds Chemical class 0.000 claims description 7
- 150000003983 crown ethers Chemical class 0.000 claims description 5
- 125000001174 sulfone group Chemical group 0.000 claims description 5
- 238000005869 desulfonation reaction Methods 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 229910052783 alkali metal Inorganic materials 0.000 claims description 2
- 150000003431 steroids Chemical class 0.000 claims 1
- 238000000034 method Methods 0.000 description 19
- 238000006243 chemical reaction Methods 0.000 description 10
- 239000002904 solvent Substances 0.000 description 9
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 8
- BHQCQFFYRZLCQQ-UHFFFAOYSA-N (3alpha,5alpha,7alpha,12alpha)-3,7,12-trihydroxy-cholan-24-oic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 BHQCQFFYRZLCQQ-UHFFFAOYSA-N 0.000 description 6
- 239000004380 Cholic acid Substances 0.000 description 6
- BHQCQFFYRZLCQQ-OELDTZBJSA-N cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 description 6
- 229960002471 cholic acid Drugs 0.000 description 6
- 235000019416 cholic acid Nutrition 0.000 description 6
- KXGVEGMKQFWNSR-UHFFFAOYSA-N deoxycholic acid Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 KXGVEGMKQFWNSR-UHFFFAOYSA-N 0.000 description 6
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 6
- 229910052751 metal Inorganic materials 0.000 description 6
- 239000002184 metal Substances 0.000 description 6
- 239000002994 raw material Substances 0.000 description 6
- RUDATBOHQWOJDD-UHFFFAOYSA-N (3beta,5beta,7alpha)-3,7-Dihydroxycholan-24-oic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)CC2 RUDATBOHQWOJDD-UHFFFAOYSA-N 0.000 description 5
- RUDATBOHQWOJDD-BSWAIDMHSA-N chenodeoxycholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)CC1 RUDATBOHQWOJDD-BSWAIDMHSA-N 0.000 description 5
- 229960001091 chenodeoxycholic acid Drugs 0.000 description 5
- 150000003839 salts Chemical class 0.000 description 5
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 230000002194 synthesizing effect Effects 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 3
- 239000003054 catalyst Substances 0.000 description 3
- GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 3
- 235000015497 potassium bicarbonate Nutrition 0.000 description 3
- 239000011736 potassium bicarbonate Substances 0.000 description 3
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 3
- 239000008096 xylene Substances 0.000 description 3
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 125000003342 alkenyl group Chemical group 0.000 description 2
- 150000001450 anions Chemical class 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- 125000001309 chloro group Chemical group Cl* 0.000 description 2
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 2
- 125000006165 cyclic alkyl group Chemical group 0.000 description 2
- JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000012044 organic layer Substances 0.000 description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 2
- 238000007086 side reaction Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 125000001424 substituent group Chemical group 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- AGMVCZWYDXQPEM-UHFFFAOYSA-N (3-bromo-1,1-diphenylpropyl)benzene Chemical compound C1(=CC=CC=C1)C(CCBr)(C1=CC=CC=C1)C1=CC=CC=C1 AGMVCZWYDXQPEM-UHFFFAOYSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- OCJBOOLMMGQPQU-UHFFFAOYSA-N 1,4-dichlorobenzene Chemical compound ClC1=CC=C(Cl)C=C1 OCJBOOLMMGQPQU-UHFFFAOYSA-N 0.000 description 1
- XRNFDHBNDUQTNB-UHFFFAOYSA-N 1-[chloro(diphenyl)methyl]-2-phenylbenzene Chemical compound C=1C=CC=CC=1C(C=1C(=CC=CC=1)C=1C=CC=CC=1)(Cl)C1=CC=CC=C1 XRNFDHBNDUQTNB-UHFFFAOYSA-N 0.000 description 1
- PQXZDDANWHYJNO-UHFFFAOYSA-N 1-bromo-10,10-dibutyltetradecane Chemical compound C(CCC)C(CCCCCCCCCBr)(CCCC)CCCC PQXZDDANWHYJNO-UHFFFAOYSA-N 0.000 description 1
- VFTFKUDGYRBSAL-UHFFFAOYSA-N 15-crown-5 Chemical compound C1COCCOCCOCCOCCO1 VFTFKUDGYRBSAL-UHFFFAOYSA-N 0.000 description 1
- XEZNGIUYQVAUSS-UHFFFAOYSA-N 18-crown-6 Chemical compound C1COCCOCCOCCOCCOCCO1 XEZNGIUYQVAUSS-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- CNEHONRSBZKTMT-UHFFFAOYSA-N 9-(bromomethyl)-9-octylheptadecane Chemical compound C(CCCCCCC)C(CBr)(CCCCCCCC)CCCCCCCC CNEHONRSBZKTMT-UHFFFAOYSA-N 0.000 description 1
- FEHVFVWKWSFHRK-UHFFFAOYSA-N 9-bromo-9-octylheptadecane Chemical compound CCCCCCCCC(Br)(CCCCCCCC)CCCCCCCC FEHVFVWKWSFHRK-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- RGBQGULUOUJOSU-UHFFFAOYSA-N C(CCCCCCC)C(CCCCBr)(CCCCCCCC)CCCCCCCC Chemical compound C(CCCCCCC)C(CCCCBr)(CCCCCCCC)CCCCCCCC RGBQGULUOUJOSU-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 description 1
- UIHCLUNTQKBZGK-UHFFFAOYSA-N Methyl isobutyl ketone Natural products CCC(C)C(C)=O UIHCLUNTQKBZGK-UHFFFAOYSA-N 0.000 description 1
- XKLIUWMXAAQGLU-UHFFFAOYSA-N [dicyclohexyl(iodo)methyl]cyclohexane Chemical compound C1CCCCC1C(C1CCCCC1)(I)C1CCCCC1 XKLIUWMXAAQGLU-UHFFFAOYSA-N 0.000 description 1
- DKFCLGCDEMSYAW-UHFFFAOYSA-N [iodo(diphenyl)methyl]benzene Chemical compound C=1C=CC=CC=1C(C=1C=CC=CC=1)(I)C1=CC=CC=C1 DKFCLGCDEMSYAW-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 125000004423 acyloxy group Chemical group 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- KMGBZBJJOKUPIA-UHFFFAOYSA-N butyl iodide Chemical compound CCCCI KMGBZBJJOKUPIA-UHFFFAOYSA-N 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 231100000315 carcinogenic Toxicity 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 150000001805 chlorine compounds Chemical class 0.000 description 1
- HRYZWHHZPQKTII-UHFFFAOYSA-N chloroethane Chemical compound CCCl HRYZWHHZPQKTII-UHFFFAOYSA-N 0.000 description 1
- 230000006326 desulfonation Effects 0.000 description 1
- YSSSPARMOAYJTE-UHFFFAOYSA-N dibenzo-18-crown-6 Chemical compound O1CCOCCOC2=CC=CC=C2OCCOCCOC2=CC=CC=C21 YSSSPARMOAYJTE-UHFFFAOYSA-N 0.000 description 1
- UNTITLLXXOKDTB-UHFFFAOYSA-N dibenzo-24-crown-8 Chemical compound O1CCOCCOCCOC2=CC=CC=C2OCCOCCOCCOC2=CC=CC=C21 UNTITLLXXOKDTB-UHFFFAOYSA-N 0.000 description 1
- 229940117389 dichlorobenzene Drugs 0.000 description 1
- BBGKDYHZQOSNMU-UHFFFAOYSA-N dicyclohexano-18-crown-6 Chemical compound O1CCOCCOC2CCCCC2OCCOCCOC2CCCCC21 BBGKDYHZQOSNMU-UHFFFAOYSA-N 0.000 description 1
- QMLGNDFKJAFKGZ-UHFFFAOYSA-N dicyclohexano-24-crown-8 Chemical compound O1CCOCCOCCOC2CCCCC2OCCOCCOCCOC2CCCCC21 QMLGNDFKJAFKGZ-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 229960003750 ethyl chloride Drugs 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 208000001130 gallstones Diseases 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- NUKZAGXMHTUAFE-UHFFFAOYSA-N hexanoic acid methyl ester Natural products CCCCCC(=O)OC NUKZAGXMHTUAFE-UHFFFAOYSA-N 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- SNHMUERNLJLMHN-UHFFFAOYSA-N iodobenzene Chemical compound IC1=CC=CC=C1 SNHMUERNLJLMHN-UHFFFAOYSA-N 0.000 description 1
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
- QTBFPMKWQKYFLR-UHFFFAOYSA-N isobutyl chloride Chemical compound CC(C)CCl QTBFPMKWQKYFLR-UHFFFAOYSA-N 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 229910052808 lithium carbonate Inorganic materials 0.000 description 1
- 229940008015 lithium carbonate Drugs 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- XKBGEWXEAPTVCK-UHFFFAOYSA-M methyltrioctylammonium chloride Chemical compound [Cl-].CCCCCCCC[N+](C)(CCCCCCCC)CCCCCCCC XKBGEWXEAPTVCK-UHFFFAOYSA-M 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 239000011356 non-aqueous organic solvent Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 229940094025 potassium bicarbonate Drugs 0.000 description 1
- 229940086066 potassium hydrogencarbonate Drugs 0.000 description 1
- FVSKHRXBFJPNKK-UHFFFAOYSA-N propionitrile Chemical compound CCC#N FVSKHRXBFJPNKK-UHFFFAOYSA-N 0.000 description 1
- 125000006239 protecting group Chemical group 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- UIIMBOGNXHQVGW-UHFFFAOYSA-M sodium bicarbonate Substances [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 239000013076 target substance Substances 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000003799 water insoluble solvent Substances 0.000 description 1
- 239000003021 water soluble solvent Substances 0.000 description 1
Landscapes
- Steroid Compounds (AREA)
Description
本発明は12位にアルキルスルホン基を有するス
テロイド化合物を脱スルホン化して△11不飽和ス
テロイド化合物を製造する方法に関し、特に該ス
テロイド化合物をアルカリ金属の重炭酸塩と第4
アンモニウム塩またはクラウンエーテルの少くと
も1種の共存下に脱スルホン化反応せしめること
を特徴とする方法に関する。
本発明の方法は11位に不飽和結合を有する各種
のステロイド化合物の合成に使用されるが、特に
コール酸よりケノデオキシコール酸(CDC)を
合成する際に有用である。
CDCは胆石溶解剤等の医薬品として有用な物
質であり、近年その安価な合成法の開発が期待さ
れている。
コール酸からCDCを合成する方法には主とし
て2通りの方法が知られており、その1つの方法
はコール酸の23位のカルボキシル基及び3位、7
位の水酸基をそれぞれエステル化して3α・7α
−ジアセトキシ−12α−ヒドロキシコラン酸メチ
ルを合成し、次いでこれを酸化して12−オキソ体
として後ウルフ、キシナー還元又は(ハンミンロ
ン還元)により12位を水素で置換する方法であ
る。
他の一つはコール酸の12位の水酸基を脱水して
△11不飽和結合とし、これに水素添加する方法で
あり、例えば、アメリカ特許第3998859号に記載
された方法等が知られている。
即ち、コール酸をジアセトキシコラン酸メチル
とし、その12位の水酸基をアルキルスルホン基に
変換し、これを溶媒としてヘキサメチルホスホト
リアミド(HMPT)を使用して酢酸塩により脱
スルホン化して△11不飽和ステロイド化合物を
得、次いで該不飽和結合に水素添加し、更に加水
分解により保護基を外して目的物を得ている。
この方法は副反応も少なく優れた方法ではある
が、溶媒として使用するHMPTは高価な物質で
あり、また、最近発ガン性の疑問がある旨の報告
もあり、工業的な製造法としては必ずしも適当な
方法であるとは言い難い。
そこで本発明者らはこの方法の改良法として工
業的に比較的安価で容易に入手でき、また、人体
に有害な作用を有しない材料を用いて前記12位に
アルキルスルホン基を有するステロイド化合物を
脱スルホン化して△11不飽和結合を有するステロ
イド化合物を合成する方法について種々検討の結
果、該反応をアルカリ金属の重炭酸塩と第4アン
モニウム塩またはクラウンエーテルの少くとも1
種の共存下に行うことにより高収率で目的物を得
ることができ、所期の目的を達成し得ることに成
功した。
以下、本発明の方法について更に詳しく説明す
る。
本発明の方法に於いて、前記金属塩及び第4ア
ンモニウム塩等は言わば、脱スルホン化剤として
の働きを有するものであり、金属塩としてリチウ
ム、ナトリウム、またはカリウムの重炭酸塩等が
用いられ、また、第4アンモニウム塩は次の一般
式で表わされる化合物が用いられる。
(ただし、R1、R2、R3およびR4はそれぞれ、アル
キル基、アルケニル基またはアリール基、Xは沃
素原子、臭素原子、塩素原子またはフツ素原子を
表わす。)
上記一般式で表わされる第4アンモニウム塩の
うち特に、R1、R2およびR3がそれぞれ炭素数1
〜8の鎖状若しくは環状のアルキル基、フエニル
基、ベンジル基または低級アルキル基で置換され
たフエニル基若しくはベンジル基であり、R4が
炭素数1〜18の鎖状若しくは環状アルキル基、炭
素数2〜4の低級アルケニル基またはベンジル基
であり、Xが塩素原子または臭素原子である化合
物が製造、精製の容易性、経済性、触媒としての
活性、安定性等の観点から最も実用的であると言
える。しかし、必ずしもこれらのみに制限される
ものではない。
本発明の方法に於ける代表的な第4アンモニウ
ム塩の例をいくつか示せば次の通りである。アン
モニウム−トリプロピルメチルヨウダイド、−ト
リプロピルエチルクロライド、−テトラプロピル
プロマイド、−トリプロピルブチルヨウダイド、−
トリプロピルオクチルヨウダイド、−トリプロピ
ルシクロヘキシルクロライド、−トリプロピルフ
エニルブロマイド、−トリブチルメチルヨウダイ
ド、トリブチルメチルブロマイド、トリブチルエ
チルブロマイド、トリブチルプロピルクロライ
ド、トリトリルメチルヨウダイド、トリキシリル
ベンジルブロマイド、トリベンジルエチルクロラ
イド、トリシクロヘキシルメチルヨウダイド、ト
リシクロベンチルイソブチルクロライド、ジメチ
ルエチルフエニルヨウダイド、ジブチルメチルフ
エニルヨウダイド、テトラブチルヨウダイド、ト
リブチルアミルブロマイド、トリブチルヘキシル
クロライド、トリブチルオクチルヨウダイド、ト
リブチルデシルブロマイド、トリブチルセチルヨ
ウダイド、トリブチルベンジルクロライド、トリ
ブチルアリルクロライド、トリブチルシクロヘキ
シルブロマイド、トリアミルメチルブロマイド、
トリヘプチルブチルクロライド、トリヘキシルメ
チルヨウダイド、トリヘキシルブチルブロマイ
ド、トリヘキシルオクチルクロライド、トリオク
チル、メチルヨウダイド、トリオクチルメチルブ
ロマイド、トリオクチルエチルブロマイド、トリ
オクチルプロピルクロライド、トリオクチルブチ
ルヨウダイド、トリオクチルアミルブロマイド、
テトラオクチルクロライド、トリオクチルセチル
ヨウダイド、トリオクチルベンジルクロライド、
トリフエニルメチルヨウダイド、トリフエニルプ
ロピルブロマイド、トリフエニルブチルヨウダイ
ド、トリフエニルヘプチルブロマイド、トリフエ
ニルベンジルクロライド等、またクラウンエーテ
ルとしては15−クラウン−5・18−クラウン−
6、ジベンゾ−18−クラウン−6、ジシクロヘキ
シル−18−クラウン−6、ジベンゾ−24−クラウ
ン−8、ジシクロヘキシル−24−クラウン−8等
が用いられ、特に、前記金属塩との組合せに於い
て、金属のイオン半径に合つたものを用いるのが
効果的である。
反応は液相状態にて行われるが、原料として使
用される前記3α・7α−ジアセトキシ−12α−
メシルオキシコラン酸メチルは融点が低く、反応
温度では液体状態を保てるため溶媒は必ずしも必
要ではない。しかし、一般に無溶媒では副反応が
増加するため、通常は適当な溶媒を用いることが
好ましい。溶媒としては水及び有機溶媒との混合
溶媒或いは非水系の有機溶媒が用いられる。溶媒
の種類により反応速度に差はあるが、原則的には
反応条件下に液状で、原料、目的物や触媒などと
反応したり、分解したりしない安定なものであれ
ば特に制限はない。実用的には、例えば、ベンゼ
ン、トルエン、キシレン、クロルベンゼン、ジク
ロルベンゼン、メチルイソブチルケトン、酢酸ブ
チル等水に不溶性の溶媒や、テトラヒドロフラ
ン、ジオキサン、アセトニトリル、プロピオニト
リル、シクロヘキサノン等の水溶性の溶媒を適宜
用いることができる。
反応条件について言えば、必ずしも厳密な制限
はないが金属塩の使用量としては原料化合物1部
に対して、通常5部〜0.1部、好ましくは2部〜
0.2部程度が適当であり、また、第4アンモニウ
ム塩又はクラウンエーテルの使用量としては原料
化合物1部に対して、通常0.2〜0.001部好ましく
は0.1部〜0.01部程度が適当である。反応温度は
使用すべき原料の種類、触媒、溶媒等の組合せに
より最適範囲が異なるが、通常は80〜150℃、好
ましくは110〜130℃の範囲で行うのが適当であ
る。反応時間についても必ずしも1律には規定し
難いが、通常の条件下では4〜15時間が適当と言
える。
尚、本発明の方法は前述の如くコール酸より
CDCを合成する過程に於いて、3α・7α−ジ
アセトキシ−12α−メシルオキシコラン酸メチル
を脱スルホン化して11位に不飽和結合を有する化
合物に変換するのに効果的に適用されるが、この
場合、12位のアルキルスルホン基はなんでも良い
わけではなく、例えば、有機合成反応に於いて脱
離基として、しばしば利用されるp−トルエンス
ルホン基、ベンゼンスルホン基等の親油性の強い
基をもつアニオンの場合には脱離してきたアニオ
ンが第4アンモニウム塩等と結合してしまい、反
応に必要な金属塩残基を油相に転移させることが
できなくなるため不適当である。従つて、12位の
アルキルスルホン基としてはメタン−エタン−等
の低級アルキル基が好適である。しかし、本発明
の脱スルホン化反応は3位、7位の置換基によつ
て影響を受けず、例えば、3位、7位が水素原子
(非置換)、水酸基、アルコキシ基、アシルオキシ
基、アルキル基等いずれでも良く、また、17位の
置換基はコール酸に相当する−CH(CH3)
CH2CH2CO2H又はその反応性誘導体例えば、エ
ステル、アミド、酸クロライド等のみに限らず他
のものでも良く、例えば、−CH(CH3)
CH2CO2H−CH(CH3)CO2H、−CO2H−
COCH3、−CH2CH3、−CH(OH)CH3等の基及び
これらの同族体並びに反応性誘導体等いずれでも
良く、各種の△11不飽和ステロイド化合物の合成
に巾広く適用することができる。
以下、本発明の方法について実施例を示し更に
具体的に説明するが、これらは言わば本発明の方
法の単なる代表例であつて、本発明はこれらのみ
に限定されないことは勿論のこと、これらによつ
て何ら制限されないことは言うまでもない。
実施例 1
3α・7α−ジアセトキシ−12α−メシルオキ
シコラン酸メチル()100g、キシレン50ml、
炭酸水素カリ150g、水100ml、触媒としてトリオ
クチルメチルアンモニウムクロライド5gを混合
し15時間110℃で反応させる。
反応終了後、炭酸水素カリ層を分離し有機層を
水洗する。目的とする3・7−ジアセトキシ−△
11コレン酸メチルの加水分解物が一部生成してい
るので組生成物をエステル化し目的物にもどす。
水洗後、有機層のキシレンを減圧留去しメタノー
ルから再結晶し、精製品72.3gを得た。
実施例 2
原料(1)10gを各種条件下に反応させた時の結果
を表に示す。
The present invention relates to a method for producing a Δ11-unsaturated steroid compound by desulfonating a steroid compound having an alkyl sulfone group at the 12-position, and in particular, it relates to a method for producing a △ 11- unsaturated steroid compound by desulfonating a steroid compound having an alkyl sulfone group at the 12-position.
The present invention relates to a method characterized in that the desulfonation reaction is carried out in the coexistence of at least one ammonium salt or crown ether. The method of the present invention is used to synthesize various steroid compounds having an unsaturated bond at the 11th position, and is particularly useful for synthesizing chenodeoxycholic acid (CDC) from cholic acid. CDC is a useful substance as a drug such as a gallstone dissolving agent, and the development of an inexpensive synthesis method is expected in recent years. There are two main methods known for synthesizing CDC from cholic acid.
By esterifying the hydroxyl groups at positions 3α and 7α, respectively
This is a method in which methyl -diacetoxy-12α-hydroxycholanate is synthesized, then oxidized to form a 12-oxo form, and then the 12th position is substituted with hydrogen by Wolff or Chisner reduction or (Hamminlon reduction). The other method is to dehydrate the 12-position hydroxyl group of cholic acid to form a △ 11 unsaturated bond, and then hydrogenate this. For example, the method described in U.S. Patent No. 3,998,859 is known. . That is, cholic acid was converted into methyl diacetoxycholanate, the hydroxyl group at the 12th position was converted to an alkylsulfone group, and this was desulfonated with acetate using hexamethylphosphotriamide (HMPT) as a solvent. An unsaturated steroid compound is obtained, then the unsaturated bond is hydrogenated, and the protecting group is removed by hydrolysis to obtain the desired product. Although this method is an excellent method with few side reactions, the HMPT used as a solvent is an expensive substance, and there have been recent reports that it may be carcinogenic, so it is not necessarily suitable as an industrial production method. It is hard to say that this is an appropriate method. In order to improve this method, the present inventors developed a steroid compound having an alkyl sulfone group at the 12-position using a material that is industrially relatively inexpensive and easily available and does not have harmful effects on the human body. As a result of various studies on methods for synthesizing steroid compounds having △ 11 unsaturated bonds by desulfonation, it was found that the reaction was carried out using at least one combination of an alkali metal bicarbonate and a quaternary ammonium salt or a crown ether.
By conducting the experiment in the presence of the species, the desired product could be obtained in high yield, and the desired objective could be achieved successfully. The method of the present invention will be explained in more detail below. In the method of the present invention, the metal salt, quaternary ammonium salt, etc. have a function as a desulfonating agent, and lithium, sodium, or potassium bicarbonate, etc. are used as the metal salt. As the quaternary ammonium salt, a compound represented by the following general formula is used. (However, R 1 , R 2 , R 3 and R 4 each represent an alkyl group, an alkenyl group or an aryl group, and X represents an iodine atom, bromine atom, chlorine atom or fluorine atom.) Represented by the above general formula Especially among the quaternary ammonium salts, R 1 , R 2 and R 3 each have 1 carbon number.
~8 chain or cyclic alkyl group, phenyl group, benzyl group, or phenyl group or benzyl group substituted with a lower alkyl group, and R 4 is a chain or cyclic alkyl group having 1 to 18 carbon atoms, carbon number Compounds in which 2 to 4 lower alkenyl groups or benzyl groups and X is a chlorine atom or a bromine atom are the most practical from the viewpoints of ease of production and purification, economic efficiency, catalytic activity, stability, etc. I can say that. However, it is not necessarily limited to these. Some representative examples of quaternary ammonium salts used in the method of the present invention are as follows. Ammonium-tripropylmethyl iodide, -tripropylethyl chloride, -tetrapropyl bromide, -tripropyl butyl iodide, -
Tripropyloctyl iodide, -tripropylcyclohexyl chloride, -tripropylphenyl bromide, -tributylmethyl iodide, tributylmethyl bromide, tributyl ethyl bromide, tributylpropyl chloride, tritolylmethyl iodide, tricylylbenzyl bromide, tribenzyl Ethyl chloride, tricyclohexylmethyl iodide, tricyclobentyl isobutyl chloride, dimethylethyl phenyl iodide, dibutylmethyl phenyl iodide, tetrabutyl iodide, tributylamyl bromide, tributylhexyl chloride, tributyloctyl iodide, tributyl decyl Bromide, tributylcetyl iodide, tributylbenzyl chloride, tributylallyl chloride, tributylcyclohexyl bromide, triamylmethyl bromide,
Triheptylbutyl chloride, trihexylmethyl iodide, trihexylbutyl bromide, trihexyl octyl chloride, trioctyl, methyl iodide, trioctyl methyl bromide, trioctyl ethyl bromide, trioctylpropyl chloride, trioctyl butyl iodide, trioctyl amyl bromide,
Tetraoctyl chloride, trioctyl cetyl iodide, trioctyl benzyl chloride,
Triphenylmethyl iodide, triphenylpropyl bromide, triphenylbutyl iodide, triphenylheptyl bromide, triphenylbenzyl chloride, etc., and as a crown ether, 15-crown-5, 18-crown-
6, dibenzo-18-crown-6, dicyclohexyl-18-crown-6, dibenzo-24-crown-8, dicyclohexyl-24-crown-8, etc. are used, especially in combination with the above metal salts, It is effective to use one that matches the ionic radius of the metal. The reaction is carried out in a liquid phase, but the 3α・7α-diacetoxy-12α- used as a raw material
Methyloxycholanate has a low melting point and can remain in a liquid state at the reaction temperature, so a solvent is not necessarily required. However, since side reactions generally increase when no solvent is used, it is usually preferable to use an appropriate solvent. As the solvent, a mixed solvent of water and an organic solvent or a non-aqueous organic solvent is used. The reaction rate varies depending on the type of solvent, but in principle there are no particular restrictions as long as it is stable under the reaction conditions, as long as it is liquid and does not react with or decompose with raw materials, target substances, catalysts, etc. Practically, for example, water-insoluble solvents such as benzene, toluene, xylene, chlorobenzene, dichlorobenzene, methyl isobutyl ketone, and butyl acetate, and water-soluble solvents such as tetrahydrofuran, dioxane, acetonitrile, propionitrile, and cyclohexanone are used. A solvent can be used as appropriate. As for the reaction conditions, there are no strict limitations, but the amount of metal salt used is usually 5 parts to 0.1 parts, preferably 2 parts to 1 part, per 1 part of the raw material compound.
About 0.2 part is appropriate, and the amount of quaternary ammonium salt or crown ether used is usually about 0.2 to 0.001 part, preferably about 0.1 part to 0.01 part, based on 1 part of the raw material compound. Although the optimum range of reaction temperature varies depending on the type of raw materials to be used, the combination of catalysts, solvents, etc., it is generally appropriate to carry out the reaction in the range of 80 to 150°C, preferably 110 to 130°C. Although it is difficult to specify a uniform reaction time, under normal conditions, 4 to 15 hours is appropriate. The method of the present invention uses cholic acid as described above.
In the process of synthesizing CDC, it is effectively applied to desulfonate methyl 3α・7α-diacetoxy-12α-mesyloxycholanate to convert it into a compound having an unsaturated bond at the 11-position. In this case, the alkyl sulfone group at the 12th position is not just arbitrary; for example, it has a strongly lipophilic group such as p-toluenesulfone group or benzenesulfone group, which is often used as a leaving group in organic synthesis reactions. In the case of anions, the released anions are unsuitable because they combine with quaternary ammonium salts and the like, making it impossible to transfer the metal salt residues necessary for the reaction to the oil phase. Therefore, a lower alkyl group such as methane-ethane- is suitable as the alkylsulfone group at the 12th position. However, the desulfonation reaction of the present invention is not affected by the substituents at the 3- and 7-positions. For example, the 3- and 7-positions are hydrogen atoms (unsubstituted), hydroxyl groups, alkoxy groups, acyloxy groups, alkyl Any group may be used, and the substituent at the 17th position is -CH(CH 3 ), which corresponds to cholic acid.
It is not limited to CH 2 CH 2 CO 2 H or its reactive derivatives such as esters, amides, acid chlorides, etc., but also other compounds such as -CH(CH 3 )
CH2CO2H −CH ( CH3 ) CO2H , −CO2H−
It can be any group such as COCH 3 , -CH 2 CH 3 , -CH(OH)CH 3 , their homologues, or reactive derivatives, and can be widely applied to the synthesis of various △ 11 unsaturated steroid compounds. can. Hereinafter, the method of the present invention will be described in more detail by showing examples, but these are merely representative examples of the method of the present invention, and it goes without saying that the present invention is not limited to these. Needless to say, there are no restrictions whatsoever. Example 1 100 g of methyl 3α・7α-diacetoxy-12α-mesyloxycholanate (), 50 ml of xylene,
150 g of potassium hydrogen carbonate, 100 ml of water, and 5 g of trioctylmethylammonium chloride as a catalyst were mixed and reacted at 110°C for 15 hours. After the reaction is completed, the potassium bicarbonate layer is separated and the organic layer is washed with water. Target 3,7-diacetoxy-△
11 Since a portion of the hydrolyzate of methyl cholenate is formed, the resulting product is esterified and returned to the desired product.
After washing with water, xylene in the organic layer was distilled off under reduced pressure and recrystallized from methanol to obtain 72.3 g of a purified product. Example 2 The results of reacting 10 g of raw material (1) under various conditions are shown in the table.
【表】【table】
Claims (1)
ド化合物をアルカリ金属の重炭酸塩と第4アンモ
ニウム塩またはクラウンエーテルの少くとも1種
の共存下に脱スルホン化反応せしめることを特徴
とする△11不飽和ステロイド化合物の製造法。1. A △ 11-unsaturated steroid characterized by subjecting a steroid compound having an alkyl sulfone group at the 12-position to a desulfonation reaction in the coexistence of an alkali metal bicarbonate and at least one quaternary ammonium salt or crown ether . Method of manufacturing compounds.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP16914080A JPS5793999A (en) | 1980-12-02 | 1980-12-02 | Preparation of delta11 unsaturated steroid |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP16914080A JPS5793999A (en) | 1980-12-02 | 1980-12-02 | Preparation of delta11 unsaturated steroid |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5793999A JPS5793999A (en) | 1982-06-11 |
| JPS6221358B2 true JPS6221358B2 (en) | 1987-05-12 |
Family
ID=15881019
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP16914080A Granted JPS5793999A (en) | 1980-12-02 | 1980-12-02 | Preparation of delta11 unsaturated steroid |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS5793999A (en) |
-
1980
- 1980-12-02 JP JP16914080A patent/JPS5793999A/en active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5793999A (en) | 1982-06-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPS6221358B2 (en) | ||
| US5808117A (en) | Process for the production of 16-Dehydropregenolone acetate form diosgenin | |
| JPS6221357B2 (en) | ||
| JPS6227078B2 (en) | ||
| CA2091615C (en) | Process for producing vitamin a acid | |
| JP2895959B2 (en) | Method for producing sulfonium salt | |
| JP3027162B2 (en) | Method for producing biphenylcarboxylic acid | |
| KR920004603B1 (en) | Method for preparing 2,2-dimethoxy-2-phenylacetophenone | |
| JPS6053039B2 (en) | N-Acetyl/Iramic acid derivative and method for producing the same | |
| JP2021063072A (en) | Method for producing 1-palmitoyl-2-linoleoyl-3-acetyl glycerol | |
| US3308132A (en) | 6, 8-dithiooctanoyl amides and intermediates | |
| JP2000344758A (en) | Method for producing (meth) acrylate | |
| US4456766A (en) | Process for the production of N-acetyl-2,3-dehydro-aminocarboxylic acid esters | |
| US3652603A (en) | Method for production of 2 3-di(lower alkoxy)-5-methyl-1 4-benzoquinone | |
| JPH02282372A (en) | Production of o-acylthiamine disulfides | |
| JP2003104951A (en) | Method for producing perfluoroalkylsulfonyl halide | |
| JP4182284B2 (en) | Method for producing 3,3-dimethylcyclopropane-1,2-dicarboxylic acid derivative | |
| US2665297A (en) | Process of producing organic unsaturated nitriles | |
| FI90068B (en) | FRUIT PROCESSING FOR A VITAMIN A ELLER DESS CARBOXYLSYRAESTRAR | |
| JPH0610164B2 (en) | Isoprenyl benzoate derivative and process for producing the same | |
| JPS5833861B2 (en) | Method for producing 3-acylamino-4-homoisotwistane | |
| JPH0236143A (en) | Production of 2-alkyl-6-acylnaphthalene | |
| JPS62273937A (en) | Production of 1-iodinated ethyl alkyl carbonate | |
| JPS5916852A (en) | Cis-bicyclo(3,3,0)octane compound | |
| JPH0159266B2 (en) |